A Doernbecher cancer patient celebrates final chemotherapy with family, neighbors in Medford.

A man who yelled racist epithets to a Black OHSU employee is charged with a hate crime.

A group of OHSU COVID-19 Wellness Task Force members, led by Megan Furnari, M.D., M.S., write detail OHSU’s efforts to respond to the pandemic and provide wellness opportunities for employees.

Stephen Spurgeon, M.D., comments on a report suggesting that patients with a form of leukemia may not follow as severe a course of COVID-19, given the susceptibility of patients with blood cancers to respiratory infections.

Atul Deodhar, M.D., discusses the efficacy of a new FDA-approved treatment for active non-radiographic axial spondyloarthritis.

OHSU is among 44 centers across the nation to be awarded federal funding to enhance training of health care professionals to treat people with substance use disorder.

The “state-of-the-art” design of the Knight Cancer Research Building is profiled. Laurie Canup, a lead architect on the building, says: “We were all united in this mission to deliver a building for them to allow them to work differently. That meant a different way of looking at what a research building can and should be.”

A Father’s Day op-ed written by Jason Campbell, M.D., focuses on the “moments stolen from too many black families."

New research led by an OHSU team examines the use of financial aid for the treatment of cardiomyopathy of transthyretin-mediated amyloidosis.

Christopher Amling, M.D., discusses the possibility that an autonomous robot could one day free surgeons from repetitive surgical tasks, improving the quality of outcomes.